We note the measure developer conducted testing to examine the need for risk adjustment to the measure for a set of factors such as patients self-reported health status, history of procedures, age, and education, and found there was not a significant relationship between the adjusted and unadjusted measure scores
For subcutaneous injections, the abdominal site is preferred for most peptides due to the consistent subcutaneous fat layer thickness, proximity to the gut-associated lymphoid tissue (relevant for some anti-inflammatory peptides), and the practical convenience of self-administration in research settings
Response timeline varies by individual and depends on baseline metabolic health, lifestyle factors, and adherence to the protocol
GHK-Cu Dosing: Five Clinical Facts You Need Before Starting The standard GHK-Cu dosage at Perfect B is 1 mg/day (4 units) for days 1-15, escalating to 2 mg/day (8 units) for days 16-30